Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

445
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
445
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

318
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
318
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

568
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
568
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

967
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
967
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

849
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
849
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

746
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
746

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"White seborrheic keratosis": a misunderstood entity in skin of color.

Annales de dermatologie et de venereologie·2026
Same author

Abietic Acid Derivatives Combining Epoxy and Anhydride Functionalities: Self- and Co-Polymerization toward Fully Bio-Based Thermosets.

Biomacromolecules·2026
Same author

Erythrosis pigmentosa mediofacialis (Brocq): A hypothesis on the involvement of Demodex folliculorum.

Annales de dermatologie et de venereologie·2025
Same author

Strong propensity to accept a diagnosis via tele-expertise in dermatology: A nationwide analysis.

Annales de dermatologie et de venereologie·2025
Same author

Two cases of bullous haemorrhagic dermatosis (BHD) induced by enoxaparin.

Annales de dermatologie et de venereologie·2024
Same author

Treatment of facial and axillary lupus miliaris with adalimumab.

Annales de dermatologie et de venereologie·2024
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.0K

[Severe edematous dermatomyositis].

R Goussot1, C Wettlé1, C Le Coz2

  • 1Service de dermatologie, clinique dermatologique, hôpital Civil, CHU, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg cedex, France.

Annales De Dermatologie Et De Venereologie
|January 1, 2016
PubMed
Summary
This summary is machine-generated.

Edematous dermatomyositis, a rare condition, presents with severe edema and requires prompt treatment. Aggressive therapy combining corticosteroids, immunosuppressants, and IV immunoglobulin is crucial for managing this severe dermatomyositis subtype.

Keywords:
DermatomyositeDermatomyositisEdemaImmunoglobulinesImmunoglobulinsŒdème

More Related Videos

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

895
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

20.2K

Related Experiment Videos

Last Updated: Mar 28, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.0K
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

895
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

20.2K

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Background:

  • Edematous dermatomyositis is a rare, severe subtype of dermatomyositis characterized by localized or generalized subcutaneous edema.
  • Only 21 cases have been previously reported, highlighting its rarity and the need for prompt therapeutic decisions.

Observation:

  • Two patients with dermatomyositis developed severe limb edema, worsening skin and muscle symptoms, and dysphagia despite initial steroid treatment.
  • One patient responded to mycophenolate mofetil and intravenous immunoglobulin, showing symptom resolution and improved muscle strength.

Findings:

  • Subcutaneous edema in dermatomyositis can indicate disease severity, often correlating with significant muscle weakness and dysphagia.
  • Aggressive treatment combining corticosteroids, immunosuppressive therapy, and intravenous immunoglobulin is necessary for effective management.

Implications:

  • Distinguishing edematous dermatomyositis from other presentations like periorbital edema or dermatomyositis with mucinosis is critical.
  • Early recognition and aggressive multi-agent therapy are vital for improving outcomes in patients with this severe dermatomyositis variant.